Spinal Muscular Atrophy Treatment Market
1 Study Coverage
1.1 Spinal Muscular Atrophy (SMA) Treatment Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Spinal Muscular Atrophy (SMA) Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size for the Year 2017-2028
1.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size for the Year 2017-2028
1.3 Spinal Muscular Atrophy (SMA) Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Spinal Muscular Atrophy (SMA) Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Spinal Muscular Atrophy (SMA) Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Spinal Muscular Atrophy (SMA) Treatment Market Dynamics
1.4.1 Spinal Muscular Atrophy (SMA) Treatment Industry Trends
1.4.2 Spinal Muscular Atrophy (SMA) Treatment Market Drivers
1.4.3 Spinal Muscular Atrophy (SMA) Treatment Market Challenges
1.4.4 Spinal Muscular Atrophy (SMA) Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Spinal Muscular Atrophy (SMA) Treatment by Type
2.1 Spinal Muscular Atrophy (SMA) Treatment Market Segment by Type
2.1.1 Type I Spinal Muscular Atrophy (SMA)
2.1.2 Type II Spinal Muscular Atrophy (SMA)
2.1.3 Type III Spinal Muscular Atrophy (SMA)
2.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2028)
2.4 United States Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2028)
3 Spinal Muscular Atrophy (SMA) Treatment by Application
3.1 Spinal Muscular Atrophy (SMA) Treatment Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Diagnostic Centers
3.1.4 Others
3.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2028)
3.4 United States Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2028)
4 Global Spinal Muscular Atrophy (SMA) Treatment Competitor Landscape by Company
4.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Company
4.1.1 Top Global Spinal Muscular Atrophy (SMA) Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Player (2017-2022)
4.2 Global Spinal Muscular Atrophy (SMA) Treatment Concentration Ratio (CR)
4.2.1 Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Spinal Muscular Atrophy (SMA) Treatment in 2021
4.2.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Spinal Muscular Atrophy (SMA) Treatment Headquarters, Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Spinal Muscular Atrophy (SMA) Treatment Headquarters and Area Served
4.3.2 Global Spinal Muscular Atrophy (SMA) Treatment Companies Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Spinal Muscular Atrophy (SMA) Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Spinal Muscular Atrophy (SMA) Treatment Market Size by Company
4.5.1 Top Spinal Muscular Atrophy (SMA) Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Spinal Muscular Atrophy (SMA) Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region
5.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2017-2028)
5.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region: 2017-2022
5.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Details
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Introduction
7.1.4 Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
7.1.5 Pfizer Recent Development
7.2 Isis Pharmaceuticals
7.2.1 Isis Pharmaceuticals Company Details
7.2.2 Isis Pharmaceuticals Business Overview
7.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction
7.2.4 Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
7.2.5 Isis Pharmaceuticals Recent Development
7.3 Biogen Idec
7.3.1 Biogen Idec Company Details
7.3.2 Biogen Idec Business Overview
7.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Introduction
7.3.4 Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
7.3.5 Biogen Idec Recent Development
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Details
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Introduction
7.4.4 Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
7.4.5 Boehringer Ingelheim Recent Development
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Company Details
7.5.2 F. Hoffmann-La Roche Business Overview
7.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Introduction
7.5.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
7.5.5 F. Hoffmann-La Roche Recent Development
7.6 Regeneron Pharmaceuticals
7.6.1 Regeneron Pharmaceuticals Company Details
7.6.2 Regeneron Pharmaceuticals Business Overview
7.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction
7.6.4 Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
7.6.5 Regeneron Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Spinal Muscular Atrophy (SMA) Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Spinal Muscular Atrophy (SMA) Treatment Market Trends
Table 3. Spinal Muscular Atrophy (SMA) Treatment Market Drivers
Table 4. Spinal Muscular Atrophy (SMA) Treatment Market Challenges
Table 5. Spinal Muscular Atrophy (SMA) Treatment Market Restraints
Table 6. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Spinal Muscular Atrophy (SMA) Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Spinal Muscular Atrophy (SMA) Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Spinal Muscular Atrophy (SMA) Treatment Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Player, 2017-2022
Table 13. Global Spinal Muscular Atrophy (SMA) Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Spinal Muscular Atrophy (SMA) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2021)
Table 15. Top Players of Spinal Muscular Atrophy (SMA) Treatment in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Spinal Muscular Atrophy (SMA) Treatment Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Spinal Muscular Atrophy (SMA) Treatment Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Spinal Muscular Atrophy (SMA) Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Spinal Muscular Atrophy (SMA) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Spinal Muscular Atrophy (SMA) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Spinal Muscular Atrophy (SMA) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Pfizer Company Details
Table 31. Pfizer Business Overview
Table 32. Pfizer Spinal Muscular Atrophy (SMA) Treatment Product
Table 33. Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 34. Pfizer Recent Development
Table 35. Isis Pharmaceuticals Company Details
Table 36. Isis Pharmaceuticals Business Overview
Table 37. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product
Table 38. Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 39. Isis Pharmaceuticals Recent Development
Table 40. Biogen Idec Company Details
Table 41. Biogen Idec Business Overview
Table 42. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product
Table 43. Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 44. Biogen Idec Recent Development
Table 45. Boehringer Ingelheim Company Details
Table 46. Boehringer Ingelheim Business Overview
Table 47. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product
Table 48. Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 49. Boehringer Ingelheim Recent Development
Table 50. F. Hoffmann-La Roche Company Details
Table 51. F. Hoffmann-La Roche Business Overview
Table 52. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product
Table 53. F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 54. F. Hoffmann-La Roche Recent Development
Table 55. Regeneron Pharmaceuticals Company Details
Table 56. Regeneron Pharmaceuticals Business Overview
Table 57. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product
Table 58. Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 59. Regeneron Pharmaceuticals Recent Development
Table 60. Research Programs/Design for This Report
Table 61. Key Data Information from Secondary Sources
Table 62. Key Data Information from Primary Sources
List of Figures
Figure 1. Spinal Muscular Atrophy (SMA) Treatment Product Picture
Figure 2. Global Spinal Muscular Atrophy (SMA) Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Spinal Muscular Atrophy (SMA) Treatment Market Size 2017-2028 (US$ Million)
Figure 4. United States Spinal Muscular Atrophy (SMA) Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Spinal Muscular Atrophy (SMA) Treatment Market Size 2017-2028 (US$ Million)
Figure 6. United States Spinal Muscular Atrophy (SMA) Treatment Market Share in Global 2017-2028
Figure 7. Spinal Muscular Atrophy (SMA) Treatment Report Years Considered
Figure 8. Product Picture of Type I Spinal Muscular Atrophy (SMA)
Figure 9. Product Picture of Type II Spinal Muscular Atrophy (SMA)
Figure 10. Product Picture of Type III Spinal Muscular Atrophy (SMA)
Figure 11. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Type in 2022 & 2028
Figure 12. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
Figure 14. United States Spinal Muscular Atrophy (SMA) Treatment Market Share by Type in 2022 & 2028
Figure 15. United States Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospitals
Figure 18. Product Picture of Ambulatory Surgical Centers
Figure 19. Product Picture of Diagnostic Centers
Figure 20. Product Picture of Others
Figure 21. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Application in 2022 & 2028
Figure 22. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
Figure 24. United States Spinal Muscular Atrophy (SMA) Treatment Market Share by Application in 2022 & 2028
Figure 25. United States Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
Figure 27. North America Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. UAE Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Pfizer Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 56. Isis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 57. Biogen Idec Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 60. Regeneron Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Industry Market Size
